LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 16 filers reported holding LAVA THERAPEUTICS NV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $379,000 | -38.2% | 128,335 | -7.9% | 0.10% | -35.6% |
| Q1 2022 | $613,000 | -20.0% | 139,332 | 0.0% | 0.16% | -17.1% |
| Q4 2021 | $766,000 | -7.2% | 139,332 | 0.0% | 0.19% | -11.9% |
| Q3 2021 | $825,000 | -44.1% | 139,332 | +2.7% | 0.22% | -29.1% |
| Q2 2021 | $1,476,000 | – | 135,632 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |